Literature DB >> 8675250

Reduced distensibility of the common carotid artery in patients treated with ergotamine.

M Barenbrock1, C Spieker, J Witta, S Evers, A P Hoeks, K H Rahn, W Zidek.   

Abstract

To investigate the effect of vascular smooth muscle contraction on mechanical vessel wall properties of proximal "elastic" arteries, we investigated the effect of the vasoconstrictor ergotamine on the distensibility of the common carotid artery in 10 migraine patients with ergotamine intake, in 10 control patients with migraine headache but no prior ergotamine intake, and in 10 healthy control subjects. The patients and control subjects were matched for age, blood pressure, and sex. In the ergotamine group, 2.2 +/- 1.4 mg ergotamine tartrate (0.25 to 6 mg) was taken within 12 hours before investigation. Differences in mean 24-hour blood pressure between the study groups were excluded by 24-hour blood pressure recording and differences in arterial wall thickness by high-resolution and differences in arterial wall thickness by high-resolution B-mode ultrasound. A multigate Doppler system was used for measurement of vessel wall movements by M-mode Doppler analysis. Blood pressure was determined by sphygmomanometry. The end-diastolic diameter of the common carotid artery was insignificantly reduced in the ergotamine group compared with the healthy control subjects and control patients (healthy control subjects, 6.6 +/- 0.4 mm; control patients, 6.7 +/- 0.5 mm; patients with ergotamine intake, 6.3 +/- 0.4 mm; P = NS). Arterial distensibility was significantly lower in the patients with ergotamine intake (17.4 +/- 4.0 10(-3)/kPa) than in the healthy control subjects (22.3 +/- 5.1 10(-3)/kPa) and control patients (22.8 +/- 3.6 10(-3)/kPa) (one-way ANOVA, P = .014). The results show that ergotamine reduces the distensibility of the common carotid artery. The data suggest that vascular smooth muscle contraction can modulate the buffering function of the arterial system independently of blood pressure changes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675250     DOI: 10.1161/01.hyp.28.1.115

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  3 in total

1.  Effect of olprinone, a phosphodiesterase III inhibitor, on arterial wall distensibility: differentiation between aorta and common carotid artery.

Authors:  M Seki; K Mizushige; T Ueda; M Kitadai; H Matsuo
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

2.  Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data.

Authors:  J N de Hoon; K A Poppe; H H Thijssen; H A Struijker-Boudier; L M Van Bortel
Journal:  Br J Clin Pharmacol       Date:  2001-07       Impact factor: 4.335

3.  Effect of early exercise engagement on arterial stiffness in patients diagnosed with a transient ischaemic attack.

Authors:  B Woolley; L Stoner; S Lark; L Wong; J Lanford; J Faulkner
Journal:  J Hum Hypertens       Date:  2014-07-03       Impact factor: 3.012

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.